SeraCare Life Sciences Announces Presentation on Enabling Clinical Genomics with Highly Multiplexed Reference Materials

MILFORD, Mass., Feb 8, 2017 /PRNewswire/ -- SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories, is announcing an upcoming webinar presentation titled “Enabling Precision Medicine with Highly Multiplexed and Patient-like Reference Materials” to be hosted by Xtalks on March 1st, 2017 at 1pm Eastern Standard Time (US).

Next generation sequencing (NGS) based clinical genomics assays are increasingly being offered by laboratories worldwide across a wide range of disease areas, including cancer, reproductive health, inherited disease, and infectious disease. Developing, optimizing, and monitoring such assays, however, can be a time consuming and challenging task.

Scientists and clinicians can build and implement robust and accurate clinical genomics assays with the help of highly multiplexed and patient-like reference materials. 

These innovative and expert-designed materials:

• Expedite assay development, improve robustness, and better characterize assays
• Help ensure confidence in the diagnostic result and overall laboratory test performance
• Enable the development of global QC standards, including proficiency materials, to allow for better inter-laboratory comparisons of performance

Join industry expert Dr. Sandi Deans, Consultant Clinical Scientist and Director of UK National External Quality Assessment Service (UK NEQAS) for Molecular Genetics as she discusses a case study of how a global external quality assessment (EQA) organization is using these reference materials to ensure the accuracy and consistency of one such clinical genomics application in non-invasive prenatal testing (NIPT). 

“As the leading provider of reference materials across the spectrum of clinical genomic assays, our goal is to enable laboratories worldwide to develop better characterized and higher performing assays.   We are very excited to share case studies that demonstrate how organizations such as UK NEQAS are using these tools in support of these fast growing clinical applications,” said Trevor Brown, Vice President of Precision Medicine at SeraCare.

Please register to attend a webinar entitled “Enabling Precision Medicine with Highly Multiplexed and Patient-like Reference Materials,” taking place on Wednesday, March 1, 2017 at 1:00pm EST, with replays available shortly after completion. Register at: https://attendee.gotowebinar.com/register/2861679502768866051?source=seracare

Additional information on SeraCare’s precision medicine products is available at: https://www.seracare.com/about-us/customers/precision-medicine/

About XTalks

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

 To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx

Contact:
Dian Razak
Tel: +1 (416) 977-6555 ext 352
Email: drazak@xtalks.com

 

About SeraCare Life Sciences Inc.

SeraCare enables the promise of precision medicine by advancing the understanding of disease and providing assurance of the diagnostic result. Our innovative tools and technologies not only ensure the safe, effective, and accurate performance of diagnostic assays but also establish a framework for regulating, compiling, and interpreting data from precision diagnostics. Our portfolio includes a broad range of products such as quality control technologies, disease-state specimens and tissues for research and development, processed biological materials, and immunoassay reagents. For more information, please visit www.seracare.com and follow SeraCare on Twitter (@SeraCare).